Clinical trial
Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung…
NCT00300729 · University Hospital, Linkoeping, Other · Unknown status
Key facts
| NCT number | NCT00300729 |
|---|---|
| Title | Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy |
| Official title | Cox-2-Inhibitor and Chemotherapy in Non-Small Cell Lung Cancer. A Prospective Randomized Double-Blind Study |
| Acronym | CYCLUS |
| Lead sponsor | University Hospital, Linkoeping, Other |
| Collaborators | Swedish Lung Cancer Study Group Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Celecoxib, Placebo |
| Enrollment | 319 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Mar 9, 2006 |
| Last update posted | Jun 30, 2009 |
| Countries | Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: